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Ureteral obstruction results in renal fibrosis in part due to
inflammatory injury. The role of interleukin-18 (IL-18), an
important mediator of inflammation, in the genesis of renal
fibrosis was studied using transgenic mice overexpressing
human IL-18-binding protein. In addition, HK-2 cells were
analyzed following direct exposure to IL-18 compared to
control media. Two weeks after ureteral obstruction, the
kidneys of wild-type mice had a significant increase in IL-18
production, collagen deposition, a-smooth muscle actin and
RhoA expression, fibroblast and macrophage accumulation,
chemokine expression, and transforming growth factor-b1
(TGF-b1) and tumor necrosis factor-a (TNF-a) production,
whereas E-cadherin expression was simultaneously
decreased. The transgenic mice with neutralized IL-18 activity
exhibited significant reductions in these indicators of
obstruction-induced renal fibrosis and epithelial–
mesenchymal transition, without demonstrating alterations
in TGF-b1 or TNF-a activity. Similarly, the HK-2 cells exhibited
increased a-smooth muscle actin expression and collagen
production, and decreased E-cadherin expression in response
to IL-18 stimulation without alterations in TNF-a or TGF-b1
activity. Our study demonstrates that IL-18 is a significant
mediator of obstruction-induced renal fibrosis and epithelial–
mesenchymal transition independent of downstream TGF-b1
or TNF-a production.
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Obstructive nephropathy is a major cause of renal dysfunc-
tion1 characterized by progressive tubulointerstitial fibrosis.2
Interstitial fibrosis is a complex pathophysiological process
involving inflammatory cell infiltration, fibroblast prolifera-
tion, and an imbalance in extracellular matrix (ECM)
synthesis, deposition, and degradation.3–5 In the kidney,
interstitial fibrosis is characterized by de novo activation of
a-smooth muscle actin (SMA)-positive myofibroblasts, the
principal effector cells responsible for excess ECM deposition.
Growing evidence suggests that renal tubular epithelial cells
(TECs) are capable of undergoing a phenotypic transforma-
tion into matrix-producing fibroblasts in pathologic states.6–9
This transformation in the phenotype of the cell epithelial–-
mesenchymal transition (EMT) is thought to contribute
greatly to renal fibrosis, with a large proportion of interstitial
fibroblasts originating from TECs.10,11 Epithelial cells that
have undergone EMT are characterized by the loss of
epithelial cell markers, such as E-cadherin, and de novo
a-SMA expression.12 The transformed epithelial cells also
begin to express fibroblast (FSP-1), a marker specific for
EMT.13 TGF-b1 can independently initiate and complete the
entire course of EMT, suggesting that induction of EMTmay
be a major pathway by which TGF-b1 stimulates interstitial
fibrosis.14–19 EMT appears to be integral to progressive TIF in
diseased kidneys,8,9,20 as selective blockade of EMT in animal
models significantly reduces obstruction-induced fibro-
sis.21,22
IL-18 is a pro-inflammatory cytokine implicated in the
pathogenesis of many inflammatory renal diseases, including
renal ischemia–reperfusion injury, allograft rejection, and
autoimmune disease.23–28 In humans, IL-18 is a sensitive and
early marker of renal tubular damage 26,29 and in animal
models of renal ischemia–reperfusion injury, IL-18 exacer-
bates acute tubular necrosis.30–32 A recent study suggests that
IL-18 can also directly stimulate fibrotic changes in renal
TECs in vitro,33 and we therefore hypothesized that IL-18 is
an important mediator of obstruction-induced renal fibrosis
and EMT. To study this we examined renal cortical IL-18
production, collagen expression and deposition, a-SMA and
RhoA expression, E-cadherin expression, FSP-1 and macro-
phage accumulation, chemokine expression, and TGF-b1 and
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TNF-a production in male C57B16 wild type (WT) mice and
mice transgenic for IL-18BP using a well-established model
of unilateral urethral obstruction (UUO). C57BL6 mice
transgenic for IL-18-binding protein transgenic (IL-18BP Tg)
have been previously demonstrated to overexpress human IL-
18-binding protein isoform a and reliably inhibit IL-18
activity.34 In addition, human proximal tubular cells (HK-2)
were directly stimulated with IL-18 and the cells were
subsequently examined for a-SMA and E-cadherin expres-
sion, collagen production, and TGF-b1 and TNF-a activity.
RESULTS
IL-18 and IL-18BP production
Before surgical intervention, serum levels of human IL-18BP
were measured and found to be dramatically elevated in the
IL-18BP Tg mice when compared with WTmice (Figure 1a).
Renal cortical tissue obtained from sham-operated animals
revealed low levels of IL-18 production; however, IL-18 levels
increased significantly in response to 1 or 2 weeks of
obstruction (Figure 1b). IL-18 gene expression was similarly
found to be significantly increased in WT animals exposed to
1 or 2 weeks of obstruction when compared with sham-
treated animals (Figure 1c), whereas no significant change in
IL-18 gene expression was detected in IL-18BP Tg animals
exposed to the same degree obstruction.
Renal tissue sections were subsequently stained for IL-18.
Minimal IL-18 was detected in sham-treated animals;
however, a significant increase in renal cortical IL-18 staining
was evident following 1 or 2 weeks of UUO (Figure 1d).
IL-18 production predominantly localized to renal TECs,
with minimal staining occurring in the glomeruli and
interstitium.
Collagen expression and deposition
Renal tissue cross sections were analyzed for collagen I and III
mRNA production and total soluble collagen concentration.
Low levels of collagen I and III mRNA were present in sham-
treated samples; however, collagen I and III mRNA expres-
sion significantly increased in WT mice exposed to 1 or 2
weeks of UUO (Figure 2a and b). In the obstructed IL-18BP
Tg animals, collagen I and III mRNA levels were increased
over sham levels, but significantly reduced when compared
with WT-obstructed mice. Similarly, total renal collagen
concentrations were significantly elevated in WT mice
exposed to 1 or 2 weeks of UUO (Figure 2c). Although
collagen concentrations were increased over sham levels in
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Figure 1 | Serum human IL-18BP levels and renal IL-18 production, quantitative mRNA expression, and immunolocalization
following UUO. (a) Serum human IL-18BP levels (pg/ml) in WT or IL-18BP transgenic (IL-18BP Tg) animals. (b) Renal cortical IL-18 protein
levels in WT sham and 1 or 2 week obstructed kidneys. (c) Quantitative IL-18 mRNA expression represented as a percentage of b-actin in WT
and IL-18BP Tg animals exposed to sham operation or 1 or 2 weeks of UUO. (d) Renal cortical immunolocalization of IL-18 production
(brown stain; arrows) in WT sham and 1- or 2-week obstructed kidneys (WT OB). G¼glomerulus; T¼ tubule; OB, obstruction; UUO,
unilateral urethral obstruction; WT, wild type. Original magnification 400.
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the 2-week obstructed IL-18BP Tg mice, collagen levels
were significantly reduced in both groups of obstructed
IL-18BP Tg animals when compared with obstructed WT
mice. This suggests that IL-18 neutralization protects against
obstruction-induced collagen gene expression and collagen
deposition.
Masson’s trichrome and a-SMA staining corroborated the
collagen findings. Although sham-operated animals exhibited
little collagen deposition and a-SMA staining (localizing only
to the vascular wall) in renal tissue sections, a significant
increase in both collagen and a-SMA deposition was evident
in the WT-obstructed kidneys (Figure 3a and b), and the
degree of collagen and a-SMA deposition was considerably
greater in the WT kidneys exposed to 2 weeks of UUO. The
1-week WT obstruction group showed moderate a-SMA and
trichrome staining (2þ ), whereas the 2-week WT obstruc-
tion group showed moderate to severe a-SMA and trichrome
staining (2 to 3þ ), each being more prominent in the
medulla. In contrast, the IL-18BP Tg samples exposed to the
same degree of obstruction exhibited mild (1þ ) a-SMA and
trichrome staining that was significantly less prominent than
that observed in the WT-obstructed samples.
a-SMA, E-cadherin, and RhoA expression
To assess IL-18’s role in obstruction-induced EMT, renal
cortical tissue was subjected to western blot analysis for
a-SMA and E-cadherin. A significant increase in a-SMA
expression was detected in WTmice subjected to 1 or 2 weeks
of UUO when compared with sham-operated animals
(Figure 4a and d). IL-18BP Tg mice subjected to the same
degree of obstruction; however, demonstrated no significant
increase in a-SMA expression. A marked reduction in
E-cadherin expression was simultaneously detected in WT
mice subjected to one or two weeks of UUO (Figure 4b);
however, no significant reduction in E-cadherin expression
was detected in obstructed IL-18BP Tg mice exposed to the
same degree of obstruction. These findings suggest that IL-18
neutralization prevents the early stages of obstruction-
induced EMT.
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Figure 2 |Renal collagen I and III mRNA expression and total collagen concentration following UUO. (a) Quantitative collagen I mRNA
expression represented as a percentage of b-actin in WT and IL-18BP transgenic (IL-18BP Tg) animals exposed to sham operation or 1 or 2
weeks of UUO. (b) Quantitative collagen III mRNA expression represented as a percentage of b-actin in WT and IL-18BP Tg animals exposed
to sham operation or 1 or 2 weeks of UUO. (c) Total soluble collagen concentration in renal tissue sections obtained from WT and IL-18BP Tg
animals exposed to sham operation or 1 or 2 weeks of UUO.
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Ras homolog gene family member A (RhoA) as mediator
of a-SMA promotor activation and EMT, was subsequently
evaluated in renal cortical tissue sections. A significant
increase in RhoA expression was detected in WT mice
subjected to 1 or 2 weeks of UUO when compared with
sham-operated animals (Figure 4c). However, IL-18BP Tg
mice subjected to the same degree of obstruction demon-
strated no increase in RhoA expression, suggesting that
IL-18-induced EMT may be mediated, in part, through
alterations in RhoA.
Fibroblast accumulation
IL-18-induced renal tubular cell EMT was further evaluated
by counting the number of FSP-1þ cells in renal cortical
tissue sections. Although the number of FSP-1þ cells
increased significantly in WT mice subjected to renal
obstruction (Figure 5a–c), and was most pronounced in
WTmice subjected to 2 weeks of renal obstruction, a marked
reduction in FSP-1þ cells was detected in both groups of
obstructed IL-18BP Tg mice when compared with WT mice.
These findings provide further evidence that IL-18 neutra-
lization prevents EMTand fibroblast accumulation within the
interstitium.
Macrophage infiltration
Renal cortical tissue sections were stained with a rat anti-
mouse macrophage antibody to assess the degree of
macrophage infiltration during renal obstruction. Although
sham-treated samples exhibited minimal macrophage stain-
ing (Figure 5a, b and d), WT mice subjected to 1 or 2 weeks
of renal obstruction demonstrated significant interstitial
macrophage accumulation. This was most pronounced in
response to 2 weeks of UUO. The degree of macrophage
accumulation, although significantly increased over sham
levels, was reduced in both groups of obstructed IL-18BP Tg
mice when compared with WT mice.
Chemokine expression
Renal cortical tissue sections were analyzed for chemokine
ligand 3 (CCL3) and chemokine ligand 4 (CCL4) mRNA
expression. A significant increase in both CCL3 and CCL4
gene expression was detected in WTmice subjected to 1 or 2
weeks of UUO (Figure 6a and b), and was most pronounced
after 2 weeks of UUO. IL-18BP Tg mice subjected to the same
degree of obstruction; however, demonstrated no increase in
CCL3 or CCL4 gene expression, suggesting that IL-18
contributes to obstruction-induced renal inflammation, in
part, through alterations in chemokine expression.
TGF-b1 production
Renal cortical tissue obtained from sham-operated animals
revealed minimal TGF-b1 mRNA expression (Figure 7a).
Relative TGF-b1 mRNA levels increased significantly in
response to 1 or 2 weeks of renal obstruction in both WT
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Figure 3 |Renal cortical a-SMA deposition and Masson’s trichrome staining following UUO. Photographs (original magnification
400) depicting renal cortical a-SMA deposition (brown stain; arrows) and collagen deposition (blue stain; arrowheads) in WT and IL-18BP
transgenic animals exposed to sham operation (WT Sham; Tg Sham) or 1 or 2 weeks of UUO (WT OB; Tg OB). a¼ arteriole; G¼glomerulus;
T¼ tubule. (a) One-week samples. (b) Two-week samples.
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and IL-18BP Tg animals; however, no difference in TGF-b1
mRNA expression was observed between WT or IL-18BP Tg
animals exposed to the same degree of obstruction.
Renal cortical active TGF-b1 protein levels were similarly
elevated in response to ureteral obstruction, as shown in
Figure 7b. Although sham-operated animals demonstrated
low levels of TGF-b1, renal cortical TGF-b1 levels increased
significantly in response to 1 or 2 weeks of obstruction in
both WT and IL-18BP Tg animals. Again, no difference in
active TGF-b1 levels were observed between WT and IL-18BP
Tg animals exposed to the same degree of obstruction.
TNF-a production
Renal cortical tissue obtained from sham-operated animals
revealed minimal TNF-a mRNA expression (Figure 8a).
Relative TNF-a mRNA levels increased significantly in
response to 1 or 2 weeks of renal obstruction in both WT
and IL-18BP Tg animals; however, no difference in TNF-a
mRNA expression was observed between WTand IL-18BP Tg
animals exposed to the same degree of obstruction.
Renal cortical TNF-a levels were similarly elevated in
response to ureteral obstruction, as shown in Figure 8b.
Although sham-operated animals demonstrated low levels of
TNF-a, renal cortical TNF-a levels increased significantly in
response to 1 or 2 weeks of obstruction in both WT and
IL-18BP Tg animals, and again, no difference in TNF-a levels
were observed between WT and IL-18BP Tg animals exposed
to UUO. These results suggest that IL-18’s downstream pro-
fibrotic effects occur independent of TGF-b1 and TNF-a
activity.
a-SMA and E-cadherin expression in vitro
To further elucidate IL-18’s role in EMT, HK-2 cells were
directly stimulated with varying concentrations of IL-18 in vitro
and examined. Cells exposed to increasing concentrations of
IL-18 demonstrated a progressive increase in a-SMA and a
progressive decrease in E-cadherin expression (Figure 9a and
b), suggesting that IL-18 stimulates the transformation of HK-2
epithelial cells into myofibroblasts. These observations were
confirmed with immunofluorescent staining for a-SMA, which
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Figure 4 |Renal cortical E-cadherin, a-SMA, and RhoA expression following UUO. (a) Densitometric analysis of a-SMA expression
represented as a percentage of GAPDH in WT and IL-18BP transgenic (IL-18BP Tg) animals exposed to sham operation or 1 or 2 weeks of
UUO. (b) Densitometric analysis of E-cadherin expression represented as a percentage of GAPDH. (c) Densitometric analysis of RhoA
expression represented as a percentage of GAPDH. (d) Gel photograph depicting E-cadherin, a-SMA, RhoA, and GAPDH expression in WT
and IL-18BP transgenic animals exposed to sham operation (WT Sham; Tg Sham) or 1 or 2 weeks of UUO (WT OB; Tg OB).
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revealed a significant increase in the number of a-SMAþ cells
in response to IL-18 stimulation (Figure 9c), and further, that
the a-SMAþ HK-2 cells had the morphological characteristics
of myofibroblasts. These characteristics were not observed in
HK-2 cells exposed to control media.
Total collagen, TNF-a, and TGF-b1 production in vitro
To investigate the secretory activity of HK-2 cells, super-
natants were collected and assayed for total collagen, TNF-a,
and TGF-b1 production following cell stimulation with
varying concentrations of IL-18. Although total collagen
production increased significantly in response to increasing
concentrations of IL-18 (Figure 10a), no increase in either
TNF-a or TGF-b1 production was observed at any
concentration of IL-18 (Figure 10b).
DISCUSSION
Tubulointerstitial fibrosis is a major pathological component
of obstructive renal injury.35 The pathophysiology of
tubulointerstitial fibrosis involves fibroblast proliferation,
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Figure 5 |Renal cortical FSP-1þ and macrophage accumulation following UUO. (a) Photographs (original magnification 400)
depicting FSP-1þ cells (brown stain; arrowheads) and macrophage (brown stain; arrows) in WT and IL-18BP transgenic animals exposed to
sham operation (WT Sham; Tg Sham) or 1 or 2 weeks of UUO (WT OB; Tg OB). G¼glomerulus; T¼ tubule. (a) One-week samples (b) Two-
week samples. (c, d) Semiquantitative renal cortical FSP-1þ and macrophage accumulation following UUO. (c). Number of FSP-1þ cells/
h.p.f. (d) Number of macrophages/h.p.f. h.p.f.¼ high-powered field.
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macrophage infiltration, the elaboration of cytokines, and an
imbalance in ECM deposition and degradation. Fibroblasts
are recognized as the principle effector cells responsible for
ECM deposition under pathologic conditions, and accumu-
lating evidence suggests that a large proportion of collagen-
producing interstitial fibroblasts originate from TECs.9,11,16
Indeed, EMT appears to be integral to renal fibrogenesis, as
selective blockade of EMT can dramatically reduce well-
established tubulointerstitial fibrosis.19,22 TGF-b1 is a major
regulator of fibrosis through stimulation of EMT and
fibroblast proliferation,12,19,21,36–39 extracellular matrix
synthesis,3,39–43 and the simultaneous inhibition of collage-
nase and degradative matrix metalloproteinases.3,39,41,44
Although increased TGF-b1 production has long been
regarded as the final common pathway in renal fibrogenesis,
this is the first study to demonstrate that IL-18 is an
important mediator of obstruction-induced renal fibrosis
and EMT independent of downstream TGF-b1, and TNF-a
production.
IL-18 is a recently discovered pro-inflammatory cytokine
that is structurally and functionally related to the IL-1 family,
and a potent stimulator of cytokine gene expression through
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Figure 6 |Quantitative renal cortical CCL3 and CCL4 mRNA
expression following UUO. (a) Quantitative CCL3 mRNA
expression represented as a percentage of GAPDH in WT and
IL-18BP transgenic (IL-18BP Tg) animals exposed to sham
operation or 1 or 2 weeks of UUO. (b) Quantitative CCL4 mRNA
expression represented as a percentage of GAPDH in WT and
IL-18BP Tg animals exposed to sham operation or 1 or 2 weeks of
UUO.
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Figure 7 |Quantitative renal cortical TGF-b1 mRNA expression
and protein production following UUO. (a) Quantitative TGF-b1
mRNA expression represented as a percentage of b-actin in WT
and IL-18BP transgenic (IL-18BP Tg) animals exposed to sham
operation or 1 or 2 weeks of UUO. (b) Active TGF-b1 protein levels
in WT and IL-18BP Tg animals exposed to sham operation or 1 or 2
weeks of UUO.
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activation of NF-kB. In humans, urinary IL-18 levels are a
sensitive and early marker of renal tubular damage from
ischemic and post-transplantation ATN,29 and in animal
models, a significant decrease in ischemia-induced renal
dysfunction and ATN has been observed in IL-18-deficient
mice.45,46 Our data reveals that renal cortical IL-18 produc-
tion is three to five times higher, and IL-18 mRNA expression
is eight times higher in obstructed kidneys when compared
with sham-operated animals. This is supported by our
observation that renal TECs show a significant increase in
IL-18 staining in response to UUO. Other studies have
documented a significant increase in circulating IL-18 levels
and IL-18 receptor expression in patients with chronic kidney
disease,25,33,47 and have similarly localized IL-18 production
to TECs in these patients.33 In conjunction with our
observations, these studies suggest that IL-18 may be an
important mediator of renal fibrogenesis.
To evaluate IL-18’s role in obstruction-induced tubuloin-
terstitial fibrosis, renal samples were analyzed for collagen I
and III gene expression, total collagen content, collagen and
a-SMA deposition, and evidence of EMT, in WTand IL-18BP
Tg mice. In addition, human proximal tubular cells (HK-2)
were directly stimulated with IL-18 and the cells subsequently
examined for a-SMA expression, collagen production, and
EMT. Our results demonstrate a significant reduction in
obstruction-induced collagen I and III mRNA expression and
total collagen concentration in mice transgenic for IL-18BP.
Furthermore, renal tissue staining revealed a marked
reduction in obstruction-induced collagen deposition (Masson’s
trichrome) and a-SMA accumulation in IL-18BP Tg animals.
These observations are supported by our in vitro studies in
which direct cell stimulation with IL-18 induced a-SMA
expression and collagen production in a concentration-
dependent fashion, and by other recent studies demonstrat-
ing that direct cell stimulation with IL-18 induces collagen I,
a-SMA, and fibronectin production in a dosage and time-
dependent fashion.33
Epithelial–mesenchymal transition was subsequently eval-
uated by examining the renal cortical expression of the
epithelial cell marker, E-cadherin, the myofibroblast marker,
a-SMA, and the fibroblast marker specific for EMT and
FSP-1. Cell morphology, a-SMA, and E-cadherin expression
were also examined following direct IL-18 stimulation
of HK-2 cells in vitro. Renal obstruction resulted
in a significant reduction in E-cadherin expression and a
simultaneous increase in a-SMA expression, indicating a
transition between epithelia and mesenchyme. This was
confirmed with the observation that increased numbers of
FSP-1þ fibroblasts were present in the interstitium of
obstructed kidneys when compared with sham-treated
controls. Overexpression of IL-18BP during renal obstruction
dramatically inhibited this process, resulting in preservation
of E-cadherin expression, a marked reduction in a-SMA
expression, and a marked decrease in the number of FSP-1þ
fibroblasts. Furthermore, direct stimulation of HK-2 cells
with IL-18 in vitro resulted in a significant reduction in
E-cadherin expression, a significant increase in a-SMA
expression, an increase in the number of a-SMAþ cells,
and the morphological conversion of a-SMAþ cells into
cells characteristic of fibroblasts. IL-18 therefore appears to
have potent pro-fibrotic properties and a direct role in the
pathogenesis of obstruction-induced EMT.
To evaluate the mechanisms of IL-18’s pro-fibrotic effect,
we investigated macrophage infiltration and the expression
and production of TGF-b1 and TNF-a during UUO in WT
and IL-18BP Tg mice. Production of TGF-b1 and TNF-a was
also evaluated following direct cell stimulation with IL-18
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Figure 8 |Quantitative renal cortical TNF-a mRNA expression
and protein production following UUO. (a) Quantitative TNF-a
mRNA expression represented as a percentage of GAPDH in WT
and IL-18BP transgenic (IL-18BP Tg) animals exposed to sham
operation or 1 or 2 weeks of UUO. (b) TNF-a protein levels in WT
and IL-18BP Tg animals exposed to sham operation or 1 or 2
weeks of UUO.
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in vitro. It has been clearly established that TGF-b1 is a major
regulator of renal fibrosis by the stimulation of fibroblast
proliferation and extracellular matrix synthesis,3,37–42,48 and
TGF-b1 is independently capable of inducing and completing
the entire EMT process in vitro.12,15–19,21,36 TNF-a also has a
role in fibrotic renal injury, stimulating ECM accumulation,
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inhibition of ECM degradation, and the upregulation of a
number of cytokines and transcription factors involved in
tubulointerstitial fibrosis, including TGF-b1 and NF-kB.49–53
Although we did observe an increase in renal TGF-b1 and
TNF-a production in response to obstruction, no reduction
in either TGF-b1 or TNF-a gene expression or protein levels
were detected in the IL-18BP Tg animals, despite the rather
dramatic decrease in obstruction-induced renal fibrosis in
these animals. Furthermore, direct stimulation of HK-2 cells
with IL-18 in vitro did not alter supernatant levels of either
TGF-b1 or TNF-a at any concentration examined, even
though the cells were undergoing molecular and morpholo-
gic changes consistent with EMT in response to IL-18. This
finding suggests that IL-18 mediates its downstream pro-
fibrotic effect independent of these two mediators. Although
the mechanism of IL-18’s pro-fibrotic effect remains unclear,
our findings do reveal that IL-18 neutralization causes a
reduction in obstruction-induced chemokine expression
(CCL3 and CCL4), macrophage infiltration, and RhoA
expression, an intracellular mediator of EMT.54 IL-18 has
also been shown to inhibit matrix metalloproteinase activity
in chondrocytes.55 It is therefore likely that IL-18 exerts its
pro-fibrotic effect by impacting signaling mediators down-
stream of TGF-b1 and TNF-a, and by stimulating inflam-
matory cell infiltration during UUO. Collectively, this is the
first demonstration that IL-18 neutralization ameliorates
obstruction-induced EMT and tubulointerstitial fibrosis in
vivo, and accordingly identifies IL-18 as an important
mediator of obstruction-induced renal injury.
Obstructive renal injury stimulates a cascade of events that
culminate in tubulointerstitial fibrosis and the conversion of
normal TECs into matrix-producing fibroblasts. This study
identifies IL-18 as an important mediator of obstruction-
induced tubulointerstitial fibrosis and EMT, independent of
downstream TGF-b1 and TNF-a activity. This represents a
novel signaling pathway in the pathogenesis of renal fibrosis,
and as the mechanism of IL-18’s pro-fibrotic effect becomes
more clearly defined, new therapeutic strategies aimed at
ameliorating renal fibrosis may be realized.
MATERIALS AND METHODS
Animals, experimental groups, and operative techniques
The animal protocol was reviewed and accepted by the Indiana
University Animal Care and Use Committee. Male C57BL6 mice
transgenic for IL-18-binding protein (IL-18 BP Tg) were generously
donated by Dr Charles Dinarello from the University of Colorado
Health Science Center, Denver, Colorado. These mice overexpress
human IL-18-binding protein isoform a and reliably inhibit IL-18
activity,34 but do not have any notable phenotype. The genotype of
the mice was confirmed with a PCR analysis of extracted DNA
samples from tail snips (50 primer, 50-ACACCTGTCTCGCAGACC
AC-30 and 30 primer, 50-TCAGCTGCTCCAGCACCAA-30) as
described by Fantuzzi et al34 and overexpression of serum levels of
human IL-18BP was confirmed using an ELISA (Figure 1a), before
utilization of the animals.
Male mice weighing 25–30 g (six animals per group) were
anesthetized with isofluorane and the left ureter was isolated and
completely ligated with 5–0 silk suture. Sham-operated mice
underwent an identical surgical procedure without ureteral ligation.
One or two weeks postoperatively, mice were re-anesthetized, the
left kidneys removed and snap frozen in liquid nitrogen, and the
animals subsequently killed.
Tissue homogenization
A portion of each renal cortex was homogenized after the samples
had been diluted in 10 volumes of homogenate buffer per gram of
tissue (10mM Hepes (pH 7.9), 10mM KCL, 0.1mM EGTA, 1mM
DTT, and Complete Protease Inhibitor tabs (Boehringer Mannheim,
Indianapolis, IN, USA)) using a vertishear tissue homogenizer.
Renal homogenates were then centrifuged at 3000 g for 15min, and
the supernatants stored at 70 1C until the ELISA assays/western
blots could be performed.
Cell culture and IL-18 stimulation
The human proximal tubular cell line HK-2 was cultured in
keratinocyte serum-free mediumþ 5 ng/ml epidermal growth factor
(EGF) and 40mg/ml bovine extractþ 100U/ml penicillin and
100Ug/ml of streptomycin. The cells were passaged weekly by
trypsinization (0.25% trypsin, 0.02% EDTA) following formation of
a confluent monolayer and placed in serum-free media 24 h before
stimulation. Recombinant mature IL-18 (R&D Systems, Minneapolis,
MN, USA) was added to the cells at concentrations of 0.1 ng/ml,
1 ng/ml, 10 ng/ml, or 100 ng/ml,33 with untreated cells serving as
controls. The cells were exposed to the single dose of IL-18 vs
untreated media for 3 days and both supernatants and cell lysates
were harvested (four plates per treatment group).
IL-18BP, IL-18, active TGF-b1, and TNF-a levels
Serum human IL-18BP levels, renal homogenate IL-18, active TGF-b1,
TNF-a, and levels, and cell supernatant active TGF-b1, and TNF-a
levels were determined using an ELISA (human IL-18BP: BD
Biosciences, San Diego, CA, USA; mouse IL-18: MBL Int., Woburn,
MA, USA; mouse and human TGF-b1: R&D Systems; mouse and
human TNF-a: BD Biosciences). For active TGF-b1, latent TGF-b1
was activated by adding 1N HCL to each sample at 1:25 for 60min
at 4 1C. The samples were then neutralized with 1N NaOH and
immediately tested. The ELISA was performed by adding 100 ml of
each sample to wells in a 96-well plate of a commercially available
ELISA kit and the assay performed according to the manufacturer’s
instructions. All samples were tested in duplicate. The ELISA results
were expressed as pg/mg protein for tissue and pg/ml for serum/
supernatant.
The renal cortical levels of IL-18 were not presented for the
IL-18BP transgenic mice because levels were dramatically higher
than WT animals in every treatment group examined, including
the shams. This led us to believe that the extreme overproduction of
IL-18BP in these animals may somehow interfere with the ELISA,
rendering it inaccurate. We therefore relied on IL-18 mRNA
production as a more accurate reflection of IL-18 production in
the IL-18BP Tg animals.
Real-time PCR
Total RNA was extracted from the renal cortical tissue by
homogenization in Trizol (Gibco BRL, Gaithersburg, MD, USA), then
isolated by precipitation with chloroform and isopropanol as
previously described.56.Total RNA (0.5mg) was subjected to cDNA
synthesis using iScript (Bio-Rad, Hercules, CA, USA). cDNA from
each sample was analyzed for IL-18 (Mm00434226_m1), Collagen 1a2
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(Mm01165187_m1), Collagen 3a1 (Mm00802331_m1), CCL3
(Mm00441259_g1), CCL4 (Mm00443111_m1), TGF-b1
(Mm01178820_m1), and TNF-a (Mm00443258_m1) using a TaqMan
gene expression assay (RT-PCR; Applied Biosystems, Foster City, CA,
USA). FAM Dye/MGB-labeled probes for either mouse b-actin or
GAPDH (Applied Biosystems) served as endogenous controls.
Tissue and cell supernatant total collagen concentration
The total soluble collagen concentration within renal cortical tissue
sections and cell supernatants (four per group) were measured with
the Sircol collagen assay kit (Accurate Chemical and Scientific,
Westbury, NY) according to the manufacturer’s protocol. Dry tissue
samples were dissolved in 0.5M acetic acid and heated for 120min
at 60 1C. Tissue suspensions were centrifuged, supernatants
collected, and the total collagen concentration measured at
540 nm in all collected supernatants.
IL-18 and a-SMA tissue staining
Tissue sections (4mm) were deparaffinized and dehydrated with
alcohol. Sections were permeabilized, subjected to an Avidin/Biotin
block (Avidin/Biotin Blocking kit; Vector labs, Burlingame, CA,
USA) for 15min, and non-specific binding sites were subsequently
blocked with normal horse serum. Slides were incubated with a goat
polyclonal anti-mouse IL-18 antibody (1:100; Santa Cruz Biotech-
nology, Santa Cruz, CA (sc-6179) overnight at 4 1C) or a mono-
clonal anti-a-SMA antibody (1:1000, 1A4 clone, DakoCytomation,
Carpinteria, CA, USA for 10min). The slides were washed in TBS
and incubated with the biotinylated secondary antibody (rabbit
anti-goat, 1:100 for 1 h) or LSAB2 Kit (1:500, DakoCytomation) for
10min. Peroxidase-stained sections were then developed with 3,3’’-
diaminobenzidine (DAB) or Streptavidin-HRP, and for IL-18,
counterstained with hemalum for 30 s. Negative controls were
performed without the primary antibody using idiotype-specific
normal goat IgG. The extent of a-SMA staining in the renal cortex
and medulla was semiquantitatively scored on a scale of 0–3, with 1
representing 5 to 15%, 2 representing 15 to 30%, and 3 representing
430% specific staining of the total kidney slice surface.
Masson’s trichrome staining
Tissue sections were deparaffinized and rehydrated with alcohol.
The slides were then washed in distilled water and stained in
Weigert’s iron hematoxylin working solution for 10min. The slides
were washed and stained in Biebrich scarlet-acid fuchsin solution for
15min. The slides were then rewashed and differentiated in
phosphomolybdic-phosphotungstic acid solution for 15min. The
tissue sections were then transferred directly to aniline blue solution
for 5–10min, rinsed, and differentiated in 1% acetic acid solution
for 2–5min. The slides were dehydrated, cleared in xylene, and
mounted. The extent of staining in the renal cortex and medulla was
semiquantitatively scored on a scale of 0–3, with 1 representing 5 to
15%, 2 representing 15 to 30%, and 3 representing 430% specific
staining of the total kidney slice surface.
Western blot analysis
Protein extracts from homogenized samples (50 mg per lane) were
subjected to SDS-PAGE electrophoresis on a Tris-Glycine gel and
transferred to a nitrocellulose membrane. Immunoblotting was
performed for each antibody by incubating each membrane in 5%
dry milk overnight at 4 1C, followed by incubation with an anti-a-
smooth muscle actin (a-SMA) monoclonal antibody (clone 1A4,
1:500 for 2 h at room temperature (RT), Sigma, St. Louis, MO,
USA), an anti-E-cadherin monoclonal antibody (1:200 overnight at
4 1C, BD Transduction Laboratories, San Jose, CA, USA), or anti-
RhoA monoclonal antibody (1:2000 for 2 h at RT, Santa Cruz
Biotechnology, Santa Cruz, CA, USA). After washing three times in
TBST, each membrane was incubated for 1 h at RT with a
peroxidase-conjugated secondary antibody (1:2000 for a-SMA,
1:1000 for E-cadherin, and 1:10,000 for RhoA). Equivalent protein
loading in each lane was confirmed by stripping and re-blotting each
membrane for GAPDH (1:20,000 for 30min at RT, secondary
1:20,000 for 30min at RT; Biodesign International, Saco, ME, USA).
The membranes were developed using enhanced chemiluminescence
(Amersham Pharmacia Biotech Inc., Piscataway, NJ, USA), and the
density of each band determined using NIH image analysis software
and expressed as a percentage of GAPDH density.
Fibroblast and macrophage accumulation
Renal tissue sections were analyzed for the presence of transformed
fibroblasts (EMT) utilizing an S100-A4 antibody (The S100-A4
antigen is also known as FSP-1)8,57,58 and macrophage infiltration
was determined with a rat anti-mouse macrophage antibody.
Transverse 4 mm renal tissue sections were deparaffinized and
dehydrated with xylene and alcohol. Antigen was retrieved by
incubating the cells with proteinase K for 20min in an oven. The
tissues were then blocked with 1% bovine serum albumin (BSA) and
incubated with a polyclonal rabbit antibody directed against S100-
A4 (FSP-1; 1:200, DakoCytomation) for 1 h at 37 1C or the rat anti-
mouse macrophage antibody (1:100, Angio-Proteomie, Boston, MA,
USA) for 90min at room temperature. Sections were washed and
incubated with a secondary antibody (goat anti-rabbit (1:50)) or
goat anti-rat (1:100) and incubated for 30min. Peroxidase-stained
sections were then developed with 3,300-diaminobenzidine and
counterstained with hematoxylin (Sigma-Aldrich, St Louis, MO).
Sections incubated without primary antibody exhibited no staining.
Spindle-shaped FSP-1-positive cells and macrophage were counted
in 10 high-powered fields ( 400) in a blinded fashion and
averaged.
Statistical analysis
Data are presented as mean values±s.e.m. Differences at the 95%
confidence level were considered significant. The experiment groups
were compared using one-way ANOVA with post hoc Bonferroni-
Dunn (JMP 5.0.1). For cell culture experiments using varying
concentrations of IL-18, a multiple-comparison analysis was
performed in all pairs using Tukey–Kramer HSD.
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